Current role of clarithromycin in the eradication of Helicobacter pylori?;Cual es el papel terapeutico actual de la claritromicina en el tratamiento erradicador de Helicobacter pylori?

Revista Espanola de Enfermedades Digestivas

Volumn 89, Issue 4, 1997, Pages 305-312

  Gisbert, J P ^a,b   Boixeda, D ^a   Martin de Argua C ^a  

^a UNIVERSITY OF ALCALÁ   (Spain)

^b Playa de Mojacar   (Spain)

Author keywords

clarithromycin; Helicobacter pylori

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; METRONIDAZOLE; OMEPRAZOLE; TINIDAZOLE; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; DRUG EFFICACY; HELICOBACTER PYLORI; HUMAN; PEPTIC ULCER; REVIEW; HELICOBACTER INFECTION; MICROBIOLOGY;

ANTI-BACTERIAL AGENTS; CLARITHROMYCIN; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS;

EID: 0031113027     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (109)

1. Marshall BJ. Helicobacter pvlori. Am J Gastroenterol. 1994;89:S116-127.
2. 3 ed. St. Louis. Mosby 1994;109-116.
3. NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. JAMA. 1994;272:65-69.
4. Chiba N, Rao BV, Rademaker JW, Hunt RH. Meta-analysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori. Am J Gastroenterol. 1992;87:1716-1722.
5. Bell GD, Powell KU, Burridge SM, et al. Experience with «triple» anti-H. pylori eradication therapy: side effects and importance of testing the pre-treatment bacterial isolate for metronidazole resistance. Aliment Pharmacol Ther. 1992;6:427-431.
6. Labenz J, Gyenes E, Rühl GH, et al. Amoxicillin plus omeprazole versus triple therapy for eradication of Helicobacter pylori in duodenal ulcer disease: a prospective, randomized, and controlled study. Gut. 1993;34:1167-1170.
7. Logan RPH, Gummett PA, Schaufelberger HD, et al. Eradication of Helicobacter pylori with clarithromycin and omeprazole. Gut 1994;35:323-326.
8. Gilbert JP, Mur M, Sainz S, Ceña G, Martin C, Sáinz R, Boixeda D, Monés J. ¿ Es útil la asociación de omeprazol y amoxicilina en el tratamiento erradicador de Helicobacter pylori en España? Rev Esp Enf Digest. 1996;88: 99-106.
9. Fernandes PB, Bailer R, Swanson R. In vitro and in vivo evaluation of A-56268 (TE-031), a new macrolide. Antimicrob Agents Chemother. 1986;30:865-873.
10. Neu HC. The development of macrolides: Clarithromycin in perspective. J Antimicrob Chemother. 1991;27(suppl. A):l-9.
11. Hardy DJ, Guay DRP, Jones RN. Clarithromycin, a unique macrolide: a pharmacokinetic, microbiological, and clinical overview. Diagn Microbiol Infect Dis. 1992;15:39-53.
12. Peterson WL, Graham D, Marshall B, et al. Clarithromycin as monotherapy for eradication of Helicobacter pylori: a randomized, double-blind trial. Am J Gastroenterol. 1993;88:1860-1864.
13. Graham DY, Operkun AR, Klein PD. Clarithromycin for the eradication of Helicobacter pylori. J Clin Gastroenterol 1993;16:292-294.
14. Hardy DJ, Hanson CW, Hensey DM, Beyer JM, Fernandes PB. Susceptibility of Campylobacter pylori to macrolides and fluoroquinolones. J Antimicrob Chemother. 1988;22:631-636.
15. Nagate T, Numata K, Hanada K, Kondo I. The susceptibility of Campylobacter pylori to antiulcer agents and antibiotics. J Clin Gastroenterol. 1990;12(suppl. 1):S135-138.
16. Lartey PA, Tanaka SK, Maring CJ, Clement JJ. Activities of four structurally diverse acid stable macrolides against Helicobacter pylori. The 1st International Conference on the macrolides. azalides and streptogramins. Santa Fe. Enero 1992.
17. Goldman RC, Zakula D, Flamm R, Beyer J, Capobianco J. Tigh binding of clarithromycin. its 14 "hydroxy metabolite, and erythromycin to Helicobacter pylori ribosomes. Antimicrob Agents Chemother. 1994;38:1496-1500.
18. Chang K, Wyle F, Skankey G, et al. Clarithromycin achieves highest gastric mucosa tissue level among anti-Helicobacter pylori antibiotics. Digestive Disease Week. Boston. Mayo 1993:A2399.
19. Gustavson LE, Kaiser JF, Murkherjee DX, Schneck DW. Evaluation of the pharmacokinetic drug interactions bet- ween clarithromycin and omeprazole. VII Workshop on Gastroduodenal Pathology and Helicobacter pylori. Houston. Octubre 1994.
20. Krajden S, Fuksa M, Anderson J, et al. Examination of human stomach biopsies, saliva and dental plaque for Campylobacter pylori. J Clin Microbiol 1989;27:1397-1398.
21. Cayla R, Lamouliane HC, Brugmann M, Mégraud F. Pretreatment resistances of Helicobacter pylori to metronidazole and macrolides. Acta Gastroenterol Belg. suppl. 1993:120.
22. López-Brea M, Martín E, Sanz JC, Moreno MJ, Martínez MJ, Alarcón T. In vitro susceptibility of Helicobacter pylori Spanish clinical isolates to clarithromycin. Acta Gastroenterol Belg. suppl. 1993;126.
23. Ghoneim AT, Langdale P, Logan R. Susceptibility of UK isolates of Helicobacter pylori to clarithromycin and metronidazole. VII Workshop on Gastroduodenal Pathology and Helicobacter pylori. Houston, Octubre 1994.
24. Ghoneim AT, Langdale P, Green R. Clarithromycin in duodenal ulcer treatment. VII Workshop on Gastroduodenal Pathology and Helicobacter pylori. Houston, Octubre 1994.
25. Weissfeld AS, Simmons DE, Busch D, et al. In vitro susceptibility of pre-treatment isolates of Helicobacter pylori from a multicenter U.S. clinical trial. VII Workshop on Gastroduodenal Pathology and Helicobacter pylori. Houston, Octubre 1994.
26. Mégraud F. Helicobacter pylori resistance to antibiotics. En: Hunt RH, Tytgat GNJ. eds. Helicobacter pylori: Basic mechanisms to clinical cure. Dordrecht, The Netherlands: Kluwer. 1994;570-583.
27. Parasakthi N, Goh KL. Primary and adquired resistance to clarithromycin among Helicobacter pylori strains in Malaysia. Am J Gastroenterol. 1995;90:519.
28. Mégraud F, Cayla R, Lamouliatte H, Bouchard S, Darmaillac V. Surveillance of Helicobacter pylori resistance to macrolides and nitroimidazole compounds at a nation level. VII Workshop on Gastroduodenal Pathology and Helicobacter pylori. Houston, Octubre 1994.
29. Xia HX, Keane CT, O'Morain CA. Prevalence and stability of clarithromycin resitances in Helicobacter pylori: Clinical implications. VII Workshop on Gastroduodenal Pathology and Helicobacter pylori. Houston. Octubre 1994.
30. López-Brea M, Domingo D, Garca Arata I, De Pedro S, Sanz JC. Antimicrobial susceptibility of metronidazole resistant Helicobacter pylori strains to clarithromycin. VII Workshop on Gastroduodenal Pathology and Helicobacter pylori. Houston, Octubre 1994.
31. López-Brea M, Domingo D, Garca Arata I, Limia A, Sanz JC, Alarcón T. Antimicrobial susceptibility of Helicobacter pylori Spanish clinical isolates. VII Workshop on Gastroduodenal Pathology and Helicobacter pylori. Houston. Octubre 1994.
32. López-Brea M, Martinez MJ, Domingo D. Sánchez Romero I, Sanz JC, Alarcón T. Evolution of the resistance of several antibiotics in Helicobacter pylori over a 4 year period. Gut. 1995;37(suppl. 1):A386.
33. Olson C, Edmonds A. Primary susceptibility of Helicobacter pylori to clarithromycin compared to metronidazole in patients with duodenal ulcers associated with Helicobacter pylori infection. Gut. 1995;37(suppl. 2):A80.
34. Craft JC, Olson C, Siepman N, Edmonds A. Clarilhromycin resistance in U.S. and European patients treated with clarithromycin and omeprazole for duodenal ulcer disease associated with Helicobacter pylori infecton. Cut. 1995; 37(suppl. 2):A80.
35. Tytgat GNY. Treatments that impact favourably upon the eradication of Helicobacter pylori and ulcer recurrence. Aliment Pharmacol Ther 1994;8:359-368.
36. Cayla R, Zerbib F, Talbi P, Mégraud F, Lamouliatte H. Pre and post-treatment clarithromycin resistance of Helicobacter pylori strains: A key factor of treatment failure. Gut. 1995;37(suppl. 1):A386.
37. Cayla R, Zerbib F, Mégraud F, Lamouliatte H. Clarithromycin resistance of Helicobacter pylori strains before and after treatment: a key factor of treatment failures. Gastroenterology. 1995;108:A68.
38. Lamouliatte H, Cayla R, Zerbib F, Talbi P, Mégraud F. Triple therapy using proton pump inhibitor-amoxicillin and clarithromycin for Helicobacter pylori eradication. Cut. 1995;37(suppl. 2):A151-152.
39. Axon ATR. The role of omeprazole and antibiotic combinations in the eradication of Helicobacter pylori - an update. Scand J Gastroenterol 1994;29(suppl. 205):31-37.
40. Logan RPH, Rubio MA, Gummett PA, et al. Omeprazole and amoxycillin suspension for Helicobacter pylori. Ir J Med Sci. 1992;161(suppl. 10): 16.
41. Logan RPH, Gummett PA, Hegarty BT, Walker MM, Baron JH, Misiewicz JJ. Clarithromycin and omeprazole for Helicobacter pylori. Lancet. 1992;340:239.
42. Logan RPH, Schaufelberger HD, Gummett PA, Baron JH, Misiewicz JJ. Eradication of Helicobacter pylori with dual therapy. The 2nd International conference on the macrolides. azalides and streptogramins. Venecia, Enero 1994.
43. Logan RPH, Bardhan KD, Celestin LR. et al. Healing of duodenal ulcer and eradication of Helicobacter pylori by clarithromycin and omeprazole. Am J Gastroenterol. 1994;89:1378.
44. Labenz J, Stolte M, Domian C, Bertrams J, Börsch G. Omeprazole plus amoxicillin or clarithromycin for eradication of H. pylori in duodena ulcer disease. Am J Gastroenterol. 1993;88:1511.
45. Burette A, Glupczynski Y, Deprez C. Omeprazole alone or in combination with clarithromycin for eradication of Helicobacter pylori: results of a randomized double-blind study. Gastroenterology. 1993;104:A49.
46. Greaves RG, Cayla R, Mendelson MG. Omeprazole vs clarithromycin and omeprazole for eradication of Helicobacter pylori. II United European Gastroenterology Week. Barcelona. Julio 1993;A101.
47. Schaufelberger HD, Logan RPH, Gummett PA, Baron JH. Misiewicz JJ. The effect of patient compliance on Helicobacter pylori eradication with dual therapy. II United European Gastroenterology Week. Barcelona, Julio 1993;A98.
48. Schaufelberger HD, Logan RPH, Misiewicz JJ. The dose and frequency of omeprazole are important in treating Helicobacter pylori with dual therapy. Gastroenterology. 1993; 104: A186.
49. Ferrini G, Laronese G, Semperlotti N. Omeprazole + clarithromycin combined treatment in the cases of duodenal ulcer associated with Helicobacter pylori. Ir J Med Sci. 1992;161(suppl. 10):99.
50. Lamouliatte H, Cayla R, Zerbib F, et al. Dual therapy versus triple therapy for Helicobacter pylori eradication. Preliminary results of a randomized controlled trial Gastroenterology. 1993;106:A120.
51. Lamouliatte H, Cayla R, Zerbib F, Mégraud F. Dual therapy (DT) versus triple therapy (TT) for Helicobacter pylori eradication: A randomized controlled study. World Congress of Gastroenterology. Los Angeles. Octubre 1994;79P.
52. Kalantzis N, Gabriel P, Giannopoulos ATH, et al. Comparative study on the efficacy of omeprazole in combination with clarithromycin or clarithromycin + ornidazole in healing duodenal ulcer and eradication Helicobacter pylori. World Congress of Gastroenterology. Los Angeles, Octubre 1994;65P.
53. Mattle WP. Omeprazole plus clarithromycin in eradicating Helicobacter pylori: a seven or fourteen day coarse of treatment with omeprazole regimes. World Congress of Gastroenterology, Los Angeles. Octubre 1994;61P.
54. Edmonds A, Reitmayer R, Debartolo M, Olson CA. Effect of smoking on Helicobacter pylori eradication in patients receiving dual therapy with clarithromycin and omeprazole. 6th International Congress for Infectious Diseases. Praga, Abril 1994.
55. Kadayifci A, Simsek H, Arslan M, Tatar G, Low dose clarithromycin plus omeprazole eradicates Helicobacter pylori in duodenal ulcer disease. Am J Gastroenterol. 1995;90:520.
56. Di Napoli A, Petrino R, Bellis D. Antral gastritis improvement after therapy of Helicobacter pylori infection with omeprazole and clarithromycin. Ital J Gastroenterol. 1991;23(suppl. 2):86.
57. Goh KL, Parasakthi N, Peh SC, et al. Clarithromycin in the treatment and eradication of Helicobacter pylori in duodenal ulcer patients. Gut. 1995;37(suppl. 1):A385.
58. Debartolo M, Reltmayer R, Olson C, Edmonds A. Effect of smoking on Helicobacter pylori eradication and duodenal ulcer recurrence in patients receiving dual therapy with clarithromycin in combination with omeprazole. Gut 1995;37(suppl. 1):A337.
59. Catalano F, Privitera U, Catanzaro R, Liberti A, Romeo MA, Branciforte G. Omeprazole plus clarithromycin: efficacy of two treatment regimens on Helicobacter pylori positive duodenal ulcer. Gut. 1995;37(suppl. 1):A163.
60. O'Morain C, Logan RPH. and the Clarithromycin European H. pylori Study Group. Clarithromycin in combination with omeprazole for healing of duodenal ulcers (DU), prevention of DU recurrence, and eradication of Helicobacter pylori in two european studies. Gut. 1995; 37(suppl. 1):A16.
61. Pueyo A, Jiménez C, Iglesias R, et al. Evaluation of therapies for the eradication of Helicobacter pylori in duodenal ulcer. Gut. 1995;37(suppl. 2):A200-201.
62. Hunt R, Schwartz H, Fitch D, Fedorak R, Al Kawas F, Vakll N. Dual therapy of clarithromycin and omeprazole for treatment of patients with duodenal ulcers associated with Helicobacter pylori infection. Gut. 1995;37(suppl. 1):A17
63. Wilde MI, McTavish D. Omeprazole: an update of its pharmacology and therapeutic use in acid-related disorders. Drugs. 1994;48:91-132.
64. De Koster E, Nyst JF, Deprez C, et al. Helicobacter pylori treatment: disappointing results with amoxicillin plus omeprazole. It J Gastroenterol. 1991;23(suppl. 2): 105.
65. Bell GD, Powell KU. Weil J. et al. Experience with omeprazole in combination with either amoxycillin or colloidal bismuth subcitrate in patients with metronidazole-resistant Helicobacter pylori. Eur J Gastroenterol Hepatol. 1991;3:923-926.
66. Bell GD, Powell KU, Burridge SM, et al. Short report: omeprazole plus antibiotic combinations for the eradication of metronidazole-resistant Helicobacter pylori. Aliment Pharmacol 1992;6:751-758.
67. Bell GD, Powell KU, Burridge SM, et al. Helicobacter pylori eradication: efficacy and side effect profile of a combination of omeprazole, amoxycillin and metronidazole compared with four alternative regimens. Q J Med. 1993;86:743-750.
68. Cayla R, Werbib F, Mascarel A De, et al. Dual therapy with high dose of omeprazole versus triple therapy using omeprazole in combination with two antibiotics for Helicobacter pylori eradication: results of a randomized controlled trial among 100 patients. Am J Gastroenterol. 1994;89:1366.
69. Bazzoli F, Zagari RM, Fossi S. Efficacy and tolerability of a short term, low dose triple therapy for eradication of Helicobacter pylori. Gastroenterology: 1993;104:A40.
70. Bazzoli F, Zagari RM, Fossi S, et al. Short-term low-dose triple therapy for the eradication of Helicobacter pylori. Eur J Gastroenterol 1994;6:773-777.
71. Bazzoli F, Gullini S, Zagari RM, et al. Effect of omeprazole and clarithromycin plus tinidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. Am J Gastroenterol. 1994;89:1364.
72. Bazzoli F, Gullini S, Zagari RM, et al. Effect of omeprazole and clarithromycin plus tinidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. Gut. 1995;37(suppl. 1):A18.
73. Moayyedi P, Axon ATR. Efficacy of a new one week triple therapy regime in eradicating Helicobacter pylori. Gut. 1994;35(suppl. 2):S62.
74. Moayyedi P, Tompkins DS, Axon ATR. Determination of the optimum dose of omeprazole in a new triple therapy regimen for eradicating Helicobacter pylori. Gut. 1994;35(suppl. 5):S16.
75. Moayyedi P, Axon ATR. Patients factors that predict failure of omeprazole, clarithromycin and tinidazole to eradicate Helicobacter pylori. Gut. 1995;37(suppl. 1):A182.
76. Jaup BH, Norrby A. Low dose short term triple therapy for eradication of Helicobacter pylori. Am J Gastroenterol. 1994;89:1400.
77. Jaup BH, Norrby A. Low dose, short-term triple therapy for cure of Helicobacter pylori infection and healing of peptic ulcer. Am J Gastroenterol. 1995;90:943-945.
78. Grasso GA, Battaglia G, Germana B, et al. Efficacy of low doses of clarithromycin for one week in eradicating Helicobacter pylori. Gut. 1995;37(suppl. 1):A187.
79. Dal Bo N, Grasso GA, Pilotto A, et al. Clarithromycin for the cure of Helicobacter pylori infection. Gut. 1994;35 (suppl. 5):W64.
80. Labenz J, Stolte M, Rühl G, et al. One-week low-dose triple therapy for the eradication of Helicobacter pylori infection. Eur J Gastroenterol. 1995;7:9-11.
81. Xia HX, Buckley M, Hyde D, Keane CT, O'Morain CA. Effects of antibiotic-resistance on clarithromycin combined triple therapy for Helicobacter pylori. Gut. 1995;37 (suppl. 1):A218.
82. Labenz J, Adamek RJ, Idström JP, Peitz U, Tillenburg B, Börsch G. Duodenal ulcer healing and Helicobacter pylori eradication by one-week low-dose triple therapy with omeprazole, clarithromycin and metronidazole. Gut. 1995;37(suppl. 1):A164.
83. Lind T, Veldhuyzen SJO, Unge P, et al. The MACH l study: Optimal one-week treatment for Helicobacter pylori defined? Gut. 1995;37(suppl. 2): A186.
84. Adamek RJ, Szymanski CH, Pfaffenbach B, Opferjuch W, Wegener M, Richken D. Short-term triple therapy of pantoprazole, clarithromycin and metronidazole for cure of Helicobacter pylori infection and cure of peptic ulcer disease. Gut. 1995;37(suppl. 2):A22.
85. Labenz J, Peitz U, Tillenburg B, Becker T, Stolte M. Efficacy and tolerability of a one-week low-dose triple therapy consisting of pantoprazole, clarithromycin and metronidazole for cure of Helicobacter pylori infection. Gut. 1995;37(suppl 2):A24.
86. Stornelli G, Rossi P, Resta S, Neve D, Rosci L, Puoti C. Evaluation of the effectiveness of a low-dose short-term triple therapy for the eradication of Helicobacter pylori infection. Gut. 1995;37(suppl. 2):A29.
87. Kamberoglou D, Georgiou S, Doulgeroglou V, Tzias V, Lagoudakis M. High eradication rate of Helicobacter pylori after a one week triple therapy regimen. Gut. 1995;37 (suppl. 2):A51.
88. Deltenre M, De Koster E, Van Gossum M, De Reuck M, Jonas C. Omeprazole based therapies for eradication of Helicobacter pylori. Gut. 1995;37(suppl. 2):A59.
89. Spadaccini A, Masciulli V, De Fanis C, et al. Ranitidine vs omeprazole: short-term triple therapy in patients with Helicobacter pylori positive duodenal ulcer. Gut. 1995;37 (suppl. 2):A204.
90. Meloni M, Cicu A, Carboni GP, et al. Short-term, low-dose triple therapy in gastritis Helicobacter pylori correlated. Gut. 1995;37(suppl. 2):A205.
91. Sabandin S, Battaglia G, Dal Bo N, et al. Clarithromycin for the cure of Helicobacter pylori infection: one or two weeks of treatment? Gastroenterology. 1995;108:A207.
92. Yousfin MM, El-Zimaity HMT. Al-Assi MT, Cole RA, Genta RM, Graham DY. Metronidazole, omeprazole, and clarithromycin: an effective combination therapy for Helicobacter pylori infection. Gastroenterology. 1995;108: A265.
93. Buckley M, Keating S, Xia H, Beattie S, Hamilton H, O'Morain C. Omeprazole plus one or two antibiotics to eradicate Helicobacter pylori. Gastroenterology. 1995;108:A63.
94. Mahir M, Johnson CD, Chir M. Is short-term triple therapy with lansoprazole, clarithromycin and metronidazole a definitive answer for Helicobacter pylori eradication? Am J Gastroenterol. 1995;90:1542-1543.
95. Gisbert JP, Boixeda D, Martín de Argua C, et al. Nuevas terapias triples de una semana de duración con metronidazol para la erradicación de Helicobacter pylori: Claritromicina o amoxicilina como segundo antibiótico. Med Clin (Barc). En prensa.
96. Gisbert JP, Boixeda D, De Rafael L, et al. ¿De qué factores depende el éxito de la triple terapia «clásica» en la eradicación de Helicobacter pylori? Rev Esp Enf Digest. 1996;88:317-322.
97. Labenz J, Adamek RJ, Tillenburg B, et al. One-week treatment with omeprazole, amoxicillin and clarithromycin or metronidazole for cure of Helicobacter pylori infection. Gut. 1995;37(suppl. 1):A172.
98. Burette A, Glupczynski Y, Deprez C, Ramdani B. Omeprazole + amoxicillin + clarithromycin therapy for Helicobacter pylori infection. Gut 1995;37(suppl. 1):A353.
99. Reilly TG, Poxon V, Walt RP. The eradication of Helicobacter pylori in practice: an audit of three clinical experience with peptic ulcer patients. Gut. 1995;37(suppl. 1):A345.
100. Goddard AF, Logan RPH, Tonge KA, et al. Eradication of Helicobacter pylori using clarithromycin. omeprazole and amoxycillin for one week. Gut. 1995;37(suppl. 1): A350.
101. Trespi E, Villani L, Broglia F, et al. High efficacy of a clarithromycin-amoxycillin-omeprazole association for Helicobacter pylori eradication and treatment of ulcer-like or reflux-like dyspeptic symptoms. Gut. 1995;37 (suppl. 1):A346.
102. Delchier JC, Elamine I, Goldfain D, Chaussade S, Mancini L, Idström JP. Comparison of omeprazole (OM) + amoxicillin (AM) versus OM + clarithromycin (CLA) in the eradication of Helicobacter pylori -Results from a randomized study involving 120 patients. Gut. 1995;37 (suppl. 1):A219.
103. Gasud (Abruzzo Group for the Study of Duodenal Ulcer), Ferrini G, De Fanis C, Delia Sciucca A, et al. Effect of omeprazole, clarithromycin and amoxicillin for a short time on Helicobacter pylori eradication. Gut. 1995;37 (suppl. 2):A247.
104. Hirschowitz BI, Mohnen J, Shaw S. Omeprazole with amoxicillin alone or with clarithromycin to treat Helicobacter pylori. Gut 1995; Gastroenterology. 1995;108: A115.
105. Hirschowitz BI, Mohnen J, Shaw S. Omeprazole with amoxicillin alone or with clarithromycin to treat Helicobacter pylori. Gut 1995; Gastroenterology. 1995;108: A115.
106. Moayyedy P, Tompkins DS, Axon ATR. Efficacy of ten days of clarithromycin, amoxycillin and omeprazole in eradicating Helicobacter pylori infection. Gut. 1995;37 (suppl. 1):A176.
107. Gisbert JP, Mur M, Boixeda D, et al. Tratamiento con omeprazol. clantromicina y amoxicilina durante una semana: elevada eficacia en la erradicación de Helicobacter pylori y en la cicatrización de la úlcera duodenal. Med Clin (Barc). En prensa.
108. Forné M, Viver JM, Espinós JC, Coll I, Tresserra F, Garau J. Impact of colloidal bismuth subcitrate in the eradication rates of Helicobacter pylori infection-associated duodenal ulcer using a short treatment regimen with omeprazole and clanthromycin: a randomized study. Am J Gastroenterol. 1995;90:718-721.
109. Gisbert JP, Boixeda D, Mur Villacampa M, Monés J, Sainz Samitier R, Martin de Argila C. Response to article by Dr. Forné et al. Am J Gastroenterol. 1996;91:176-177.